Skip to content

Drug interactions

Durvalumab + Siponimod

Severity: Moderate

Durvalumab and Siponimod: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Durvalumab enhances immune activity rather than suppressing it, but immune-related adverse events are often treated with immunosuppressants, and siponimod lowers lymphocytes. The combination may blunt anti-tumor immunity and raise infection risk, though evidence is limited.

What this interaction means in plain words

Durvalumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Durvalumab belongs to Oncology; Siponimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Pharmacodynamic opposition: siponimod sequesters lymphocytes that checkpoint blockade relies on; the exact clinical effect is not well established.

What to do

Monitor lymphocyte counts and infections, and review the need for siponimod in patients on checkpoint inhibitors. Consult oncology and neurology before combining.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Durvalumab and Siponimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Durvalumab with Siponimod?

MediHelp rates the interaction as moderate. Durvalumab and Siponimod can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Durvalumab enhances immune activity rather than suppressing it, but immune-related adverse events are often treated with immunosuppressants, and siponimod lowers lymphocytes. The combination may blunt anti-tumor immunity and raise infection risk, though evidence is limited.

How serious is the interaction between Durvalumab and Siponimod?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor lymphocyte counts and infections, and review the need for siponimod in patients on checkpoint inhibitors. Consult oncology and neurology before combining.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in